Eagle Bay Advisors’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Eagle Bay Advisors’s Portfolio MBVX Stock Details MBVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23	Closed	–	–	1040
2022 Q3	$0	Hold	23	–	–	﹤0.01%	998
2022 Q2	$0	Buy	+23	New	–	﹤0.01%	1151
2022 Q1	–	Sell	-23	Closed	-$1K	–	1074
2021 Q4	$1K	Hold	23	–	–	﹤0.01%	1091
2021 Q3	$0	Buy	+23	New	–	﹤0.01%	1204

Eagle Bay Advisors's MBVX Position: Q4 2022 in Review

Eagle Bay Advisors sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q4 2022, closing a stake of 23 shares.

Eagle Bay Advisors first reported a position in MBVX in Q3 2021 and held it in 4 quarters. The position peaked at $1K in Q4 2021. 0 funds tracked by Wall St. Rank hold MBVX as of Q4 2022.

Eagle Bay Advisors reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q4 2022 after selling out during the quarter.
Eagle Bay Advisors sold 23 MABVAX THERAPEUTICS HLDGS INC shares in Q4 2022.
Eagle Bay Advisors first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q3 2021 and held it in 4 quarters.
Eagle Bay Advisors's MABVAX THERAPEUTICS HLDGS INC position peaked at $1K in Q4 2021.
0 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q4 2022.

Based on Eagle Bay Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.